25
Descriptive Assessment of Eye Cataracts in the Jirel Population, Nepal, March 2015 Jose Escarcega Mentor: Matthew P. Johnson, Ph.D. Associate Professor South Texas Diabetes and Obesity Institute School of Medicine University of Texas Rio Grande Valley

Presentation_Jose_Escarcega_BrownsvilleSummer_7-27-15_2155 (final)

Embed Size (px)

Citation preview

Page 1: Presentation_Jose_Escarcega_BrownsvilleSummer_7-27-15_2155 (final)

Descriptive Assessment of Eye Cataracts in the Jirel Population, Nepal, March 2015

Jose Escarcega

Mentor: Matthew P. Johnson, Ph.D.Associate ProfessorSouth Texas Diabetes and Obesity InstituteSchool of MedicineUniversity of Texas Rio Grande Valley

Page 2: Presentation_Jose_Escarcega_BrownsvilleSummer_7-27-15_2155 (final)

Introduction

Page 3: Presentation_Jose_Escarcega_BrownsvilleSummer_7-27-15_2155 (final)

Visual Impairment•Defined as blindness and/or poor vision•Approximately 11% of the world’s

population is visually impaired•Important public health issue•Burdens health care systems

Page 4: Presentation_Jose_Escarcega_BrownsvilleSummer_7-27-15_2155 (final)

Cataracts•Defined as clouding of the lens

▫This results from proteins ‘clumping’ together

•Leading cause of visual impairment, globally

•Higher prevalence in developing countries

•Risk factors include: age, UV exposure, and smoking

Page 5: Presentation_Jose_Escarcega_BrownsvilleSummer_7-27-15_2155 (final)

The Jirel people of Dolakha District, eastern Nepal

Page 6: Presentation_Jose_Escarcega_BrownsvilleSummer_7-27-15_2155 (final)

Purpose•To perform descriptive statistics of self-

and clinician-reported data from the Jirel population, focusing on cataract disease.

•To determine if there were any

correlations between variables studied that could help explain ocular-related pathology in this population, specifically cataract disease.

Page 7: Presentation_Jose_Escarcega_BrownsvilleSummer_7-27-15_2155 (final)

Methods

Page 8: Presentation_Jose_Escarcega_BrownsvilleSummer_7-27-15_2155 (final)

Overview of Methods: Study Design

Data were provided to J. Escarcega for analysis regarding cataract disease

Investigators enter data into an Excel database

First data collection session by Dr. Johnson and his colleagues

Page 9: Presentation_Jose_Escarcega_BrownsvilleSummer_7-27-15_2155 (final)

Variables Analyzed•Demographic

▫Gender, age•Social

▫Smoking, alcohol, tobacco chewing•Clinical

▫Systemic illness, hypertension, diabetes, asthma, cerebrovascular accident

Page 10: Presentation_Jose_Escarcega_BrownsvilleSummer_7-27-15_2155 (final)

Results

Page 11: Presentation_Jose_Escarcega_BrownsvilleSummer_7-27-15_2155 (final)

Demographic Analyses

Page 12: Presentation_Jose_Escarcega_BrownsvilleSummer_7-27-15_2155 (final)

Gender Distribution

39%

61%

Gender Distribution of the Jirel Eye Cataract Study Population

MaleFemale

N=229

Page 13: Presentation_Jose_Escarcega_BrownsvilleSummer_7-27-15_2155 (final)

Age Distribution by Gender Male Female Total

Age <49 47 90 137Age >50 42 50 92Total 89 140 229

Page 14: Presentation_Jose_Escarcega_BrownsvilleSummer_7-27-15_2155 (final)

Age Distribution

0-19 20-39 40-59 60-79 80-990

10

20

30

40

50

60

70

80

90

100

11

76

91

43

8

Age groups

Num

ber

of p

atie

nts

Page 15: Presentation_Jose_Escarcega_BrownsvilleSummer_7-27-15_2155 (final)

Social DeterminantsBehavior Use Don’t UseSmoking 26% 74%

Alcohol Use 56% 44%Tobacco Chewing 13% 87%

N=229

Page 16: Presentation_Jose_Escarcega_BrownsvilleSummer_7-27-15_2155 (final)

Clinical FindingsDisease Yes No Data not

Available

Systemic Illness 56% 44% 0%Hypertension 12% 85% 3%

Diabetes 5% 92% 3%Asthma 5% 92% 3%

Cerebrovascular Accident 0% 97% 3%

Page 17: Presentation_Jose_Escarcega_BrownsvilleSummer_7-27-15_2155 (final)

Association between selected variables and cataract disease

Variable P-ValueAge 2.38e-13

Gender 0.674Smoking 0.01645Alcohol 0.8052Tobacco 0.6305

Systemic Illness 0.00155Hypertension 0.001881

Diabetes 0.05916Asthma 0.01398

Page 18: Presentation_Jose_Escarcega_BrownsvilleSummer_7-27-15_2155 (final)

Conclusions

Page 19: Presentation_Jose_Escarcega_BrownsvilleSummer_7-27-15_2155 (final)

Conclusions:•Demographics: >60% female

•Social Determinants: 56% alcohol use, 26% smoking

•Clinical Findings: 56% systemic illness, 12% hypertension

Page 20: Presentation_Jose_Escarcega_BrownsvilleSummer_7-27-15_2155 (final)

Association of Variables with Cataract Disease•Age> Hypertension> Systemic Illness>

Asthma> Smoking

•These associations make sense biologically

Page 21: Presentation_Jose_Escarcega_BrownsvilleSummer_7-27-15_2155 (final)

Limitations•Small sample size

•Categorized cataract types into one group to maximize study power

•Only able to analyze selected variables▫As a result, not able to study all the

possible associations between variables and cataract disease

Page 22: Presentation_Jose_Escarcega_BrownsvilleSummer_7-27-15_2155 (final)

Future Studies•Study more variables related to cataracts

and other eye diseases

•Determine additional risk factors

Page 23: Presentation_Jose_Escarcega_BrownsvilleSummer_7-27-15_2155 (final)

Acknowledgements• Research funding

▫ NIH/NEI grant number EY024384 (Johnson/Williams-Blangero)

• Personnel▫ South Texas Diabetes & Obesity Institute, UTRGV, Brownsville, TX: Matthew

P. Johnson, Ph.D.; Sarah Williams-Blangero, Ph.D.; John Blangero, Ph.D.; Sandy Laston, R.N., Ph.D.

• Tilganga Institute of Ophthalmology, Kathmandu, Nepal:▫ Suman S. Thapa, M.D., Ph.D.; Mohan K. Shrestha, M.P.H. 

• Miami University, Oxford, OH: ▫ Janardan Subedi, Ph.D.

• Wright State University, Kettering, OH: ▫ Bradford Towne, Ph.D.

Page 24: Presentation_Jose_Escarcega_BrownsvilleSummer_7-27-15_2155 (final)

Thank you!•The University of Texas School of Public

Health, Brownsville Regional Campus▫Matthew P. Johnson, PhD

•The University of Texas at Austin▫Leanne Field, PhD

Page 25: Presentation_Jose_Escarcega_BrownsvilleSummer_7-27-15_2155 (final)

Questions?